CDKN2A and non-small cell lung carcinoma: In this study, we demonstrated that factors associated with poor outcomes in stage I and II nonsquamous NSCLC included nonadenocarcinoma, positive expression of p16INK4 and RB1 by IHC, and with CNV of CDKN2A gene in the tumor cells.